HomepageMedicineIDEAYA Names Stu Dorman as New Chief Commercial Officer Medicine IDEAYA Names Stu Dorman as New Chief Commercial Officer admin Posted on November 22, 2024 Dorman previously served as head of Gilead Sciences’ U.S. Oncology Unit. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostLitter Robot 4 Review 2024: How It Measured Up in My Multi-Cat Home Next PostHow to Plan a Family Heritage Trip You Might Also Like Medicine Aurlumyn Becomes First Severe Frostbite Medication to Receive FDA Approval admin February 15, 2024 Medicine JPM25: Oncology Outlook for 2025 admin January 20, 2025 Medicine Pharma Pulse 3/15/24:Pharma Dealt Loss Over Discount Program, Adopting New Manufacturing Technologies & more admin March 17, 2024 Medicine Pharma Pulse 5/24/24: Counsel Patients on Nutrition and Following a Balanced Diet Complementary to GLP-1s, Neuralink’s First Brain-Implant Patient Stays Upbeat & more admin May 26, 2024
Medicine Aurlumyn Becomes First Severe Frostbite Medication to Receive FDA Approval admin February 15, 2024
Medicine Pharma Pulse 3/15/24:Pharma Dealt Loss Over Discount Program, Adopting New Manufacturing Technologies & more admin March 17, 2024
Medicine Pharma Pulse 5/24/24: Counsel Patients on Nutrition and Following a Balanced Diet Complementary to GLP-1s, Neuralink’s First Brain-Implant Patient Stays Upbeat & more admin May 26, 2024